ES8701157A1 - Un procedimiento para la preparacion de derivados de secocantina. - Google Patents
Un procedimiento para la preparacion de derivados de secocantina.Info
- Publication number
- ES8701157A1 ES8701157A1 ES544729A ES544729A ES8701157A1 ES 8701157 A1 ES8701157 A1 ES 8701157A1 ES 544729 A ES544729 A ES 544729A ES 544729 A ES544729 A ES 544729A ES 8701157 A1 ES8701157 A1 ES 8701157A1
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- hydrogen
- phenyl
- cycloalkyl
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 7
- 229910052739 hydrogen Inorganic materials 0.000 abstract 7
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- -1 polymethylen Polymers 0.000 abstract 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052736 halogen Chemical group 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Substances 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- CREXVNNSNOKDHW-UHFFFAOYSA-N azaniumylideneazanide Chemical group N[N] CREXVNNSNOKDHW-UHFFFAOYSA-N 0.000 abstract 1
- 239000003937 drug carrier Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000006413 ring segment Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
PROCEDIMIENTO DE DERIVADOS DE SECOCANTINA, DE FORMULA (I), Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES. CONSISTE EN UNA REACCION DE DEGRADACION DE CURTIUS DE UN COMPUESTO DE FORMULA (II), CON LO QUE SE OBTIENE UN COMPUESTO DE FORMULA (I), EN LA QUE R7 REPRESENTA HIDROGENO O ALQUILO C1-4 Y R1-R6 PUEDEN SER VARIOS TIPOS DE RADICALES. LA DEGRADACION SE LLEVA A CABO POR CALENTAMIENTO A REFLUJO EN BENCENO SECO SEGUIDO DE LA HIDROLISIS DEL ISOCIANATO ASI FORMADO EN CONDICIONES ACIDAS. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE TRASTORNOS CEREBROVASCULARES Y ASOCIADOS CON LA SENSIBILIDAD CEREBRAL.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848416724A GB8416724D0 (en) | 1984-06-30 | 1984-06-30 | Active compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8701157A1 true ES8701157A1 (es) | 1986-11-16 |
| ES544729A0 ES544729A0 (es) | 1986-11-16 |
Family
ID=10563258
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES544729A Expired ES8701157A1 (es) | 1984-06-30 | 1985-06-28 | Un procedimiento para la preparacion de derivados de secocantina. |
| ES552655A Expired ES8704166A1 (es) | 1984-06-30 | 1986-03-04 | Un procedimiento para la preparacion de derivados de secocantina |
| ES552653A Expired ES8704164A1 (es) | 1984-06-30 | 1986-03-04 | Un procedimiento para la preparacion de derivados de secocantina |
| ES552654A Expired ES8704165A1 (es) | 1984-06-30 | 1986-03-04 | Un procedimiento para la preparacion de derivados de secocantina |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES552655A Expired ES8704166A1 (es) | 1984-06-30 | 1986-03-04 | Un procedimiento para la preparacion de derivados de secocantina |
| ES552653A Expired ES8704164A1 (es) | 1984-06-30 | 1986-03-04 | Un procedimiento para la preparacion de derivados de secocantina |
| ES552654A Expired ES8704165A1 (es) | 1984-06-30 | 1986-03-04 | Un procedimiento para la preparacion de derivados de secocantina |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4853391A (es) |
| EP (1) | EP0167901B1 (es) |
| JP (1) | JPH0699430B2 (es) |
| AT (1) | ATE51623T1 (es) |
| AU (1) | AU583520B2 (es) |
| CA (1) | CA1296730C (es) |
| DE (1) | DE3576956D1 (es) |
| ES (4) | ES8701157A1 (es) |
| GB (1) | GB8416724D0 (es) |
| GR (1) | GR851602B (es) |
| IE (1) | IE58102B1 (es) |
| MX (1) | MX164198B (es) |
| NZ (1) | NZ212588A (es) |
| ZA (1) | ZA854902B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0213696B1 (en) | 1985-06-28 | 1991-01-23 | Beecham Wuelfing GmbH & Co KG | Tetrahydropyrido [1,2-a] indole derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
| US4624954A (en) * | 1985-12-20 | 1986-11-25 | American Home Products Corporation | 6,7,8,9-tetrahydro-10-methylpyrido[1,2-a]indol-9-amines and derivatives thereof, useful for the treatment of cognitive impairments |
| EP0252643A1 (en) | 1986-07-01 | 1988-01-13 | BEECHAM - WUELFING GmbH & Co. KG | Pyrido[1,2-a]indole derivatives, process for their preparation and pharmaceutical compounds containing them |
| CA1329597C (en) * | 1986-12-22 | 1994-05-17 | Dagmar Hoeltje | Derivatives of tetrahydropyrido[1,2-a]indole |
| US5290785A (en) * | 1988-09-27 | 1994-03-01 | Fujisawa Pharmaceutical Co., Ltd. | Therapeutic agent for ischemic diseases |
| GB9819035D0 (en) | 1998-09-01 | 1998-10-28 | Cerebrus Res Ltd | Chemical compounds VII |
| PT1149078E (pt) * | 1998-12-11 | 2006-07-31 | Univ Virginia Commonwealth | Ligandos receptores de 5-ht6 selectivos |
| EP1693366A1 (en) * | 1998-12-11 | 2006-08-23 | Virginia Commonwealth University | Selective 5-HT 6 receptor ligands |
| EP1132389A1 (en) * | 2000-03-06 | 2001-09-12 | Vernalis Research Limited | New aza-indolyl derivatives for the treatment of obesity |
| AU2002322720B2 (en) | 2001-07-25 | 2008-11-13 | Raptor Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| MX2007005199A (es) | 2004-11-01 | 2007-05-11 | Wyeth Corp | Indolizinas sustituidas y derivados como agentes del sistema nervioso central. |
| CN102379684B (zh) | 2005-04-28 | 2014-11-19 | 普罗透斯数字保健公司 | 药物信息系统 |
| KR20090071598A (ko) | 2006-09-18 | 2009-07-01 | 랩터 파마슈티컬 인코포레이티드 | 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료 |
| EP2398500B1 (en) | 2009-02-20 | 2019-03-13 | 2-BBB Medicines B.V. | Glutathione-based drug delivery system |
| ES2942923T3 (es) | 2009-05-06 | 2023-06-07 | Laboratory Skin Care Inc | Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1550496A (en) * | 1976-12-31 | 1979-08-15 | Logeais Labor Jacques | 1,2,3,3a4,5-hexahydro-canthine derivatives a process for their preparation and their therapeutic applications |
| US4328343A (en) * | 1978-03-13 | 1982-05-04 | The United States Of America As Represented By The Department Of Health And Human Services | Cobalt-catalyzed one-step synthesis of annulated pyridines |
| EP0036269A1 (en) * | 1980-03-15 | 1981-09-23 | Beecham Group Plc | Substituted benzamides |
| US4595688A (en) * | 1983-06-23 | 1986-06-17 | Mcneilab, Inc. | Hexahydropyrrolo[2,1-a]isoquinoline derivatives and antidepressant use thereof |
| EP0213696B1 (en) * | 1985-06-28 | 1991-01-23 | Beecham Wuelfing GmbH & Co KG | Tetrahydropyrido [1,2-a] indole derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
| US4624954A (en) * | 1985-12-20 | 1986-11-25 | American Home Products Corporation | 6,7,8,9-tetrahydro-10-methylpyrido[1,2-a]indol-9-amines and derivatives thereof, useful for the treatment of cognitive impairments |
-
1984
- 1984-06-30 GB GB848416724A patent/GB8416724D0/en active Pending
-
1985
- 1985-06-20 AT AT85107634T patent/ATE51623T1/de not_active IP Right Cessation
- 1985-06-20 DE DE8585107634T patent/DE3576956D1/de not_active Expired - Lifetime
- 1985-06-20 EP EP85107634A patent/EP0167901B1/en not_active Expired - Lifetime
- 1985-06-27 AU AU44243/85A patent/AU583520B2/en not_active Ceased
- 1985-06-28 GR GR851602A patent/GR851602B/el unknown
- 1985-06-28 MX MX8192A patent/MX164198B/es unknown
- 1985-06-28 NZ NZ212588A patent/NZ212588A/xx unknown
- 1985-06-28 ES ES544729A patent/ES8701157A1/es not_active Expired
- 1985-06-28 CA CA000485991A patent/CA1296730C/en not_active Expired - Fee Related
- 1985-06-28 IE IE163385A patent/IE58102B1/en not_active IP Right Cessation
- 1985-06-28 ZA ZA854902A patent/ZA854902B/xx unknown
- 1985-06-28 US US06/750,038 patent/US4853391A/en not_active Expired - Lifetime
- 1985-07-01 JP JP60144423A patent/JPH0699430B2/ja not_active Expired - Lifetime
-
1986
- 1986-03-04 ES ES552655A patent/ES8704166A1/es not_active Expired
- 1986-03-04 ES ES552653A patent/ES8704164A1/es not_active Expired
- 1986-03-04 ES ES552654A patent/ES8704165A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ZA854902B (en) | 1986-05-28 |
| EP0167901A2 (en) | 1986-01-15 |
| CA1296730C (en) | 1992-03-03 |
| ES552653A0 (es) | 1987-03-16 |
| IE851633L (en) | 1985-12-30 |
| JPH0699430B2 (ja) | 1994-12-07 |
| GR851602B (es) | 1985-11-25 |
| EP0167901A3 (en) | 1987-05-13 |
| DE3576956D1 (de) | 1990-05-10 |
| AU583520B2 (en) | 1989-05-04 |
| ES8704165A1 (es) | 1987-03-16 |
| ES552655A0 (es) | 1987-03-16 |
| US4853391A (en) | 1989-08-01 |
| ATE51623T1 (de) | 1990-04-15 |
| GB8416724D0 (en) | 1984-08-01 |
| IE58102B1 (en) | 1993-06-30 |
| NZ212588A (en) | 1989-01-06 |
| ES544729A0 (es) | 1986-11-16 |
| MX164198B (es) | 1992-07-23 |
| ES552654A0 (es) | 1987-03-16 |
| AU4424385A (en) | 1986-01-02 |
| ES8704164A1 (es) | 1987-03-16 |
| ES8704166A1 (es) | 1987-03-16 |
| EP0167901B1 (en) | 1990-04-04 |
| JPS6130587A (ja) | 1986-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8704164A1 (es) | Un procedimiento para la preparacion de derivados de secocantina | |
| ES8800150A1 (es) | Un procedimiento para la preparacion de derivados de indol | |
| ATE132150T1 (de) | 3-alkenyl-1-azabicyclo(3.2.0)hept-2-en-2- carbonsäure-verbindungen | |
| ES8401941A1 (es) | Procedimiento para la preparacion de derivados de acido espiro (4.(3+n))-2-aza-3carboxilico. | |
| DK555387A (da) | Benzimidazolderivater | |
| NO154089C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
| EP0614661A3 (en) | Benzylidene and cinnamylidene malononitrile derivatives to inhibit proliferative processes in mammalian cells. | |
| EP0254327A3 (en) | N-n-disubstituted-omega-(2-amino-3-(carbonylmethyl)-3,4-dihydroquinazolinyl) oxyalkylamides and related compounds | |
| GR861014B (en) | Substituted n-((4-piperidinyl)alkyl) bicyclic condensed oxazol-and thiazolamines | |
| ES8200669A1 (es) | Un procedimiento para la preparacion de nuevos compuestos iminicos heterociclicos | |
| IT1213301B (it) | Composizioni per il trattamento del le sindromi da ischemia e riperfusione | |
| EA200000527A3 (ru) | Новые бициклические амино-пиразиноновые соединения, способ их получения и фармацевтические композиции, содержащие их | |
| ATE46347T1 (de) | Immunostimulierende peptide. | |
| SE7412163L (es) | ||
| ES8802313A1 (es) | Un procedimiento para la preparacion de aminoalquil secocantinas. | |
| ES8800942A1 (es) | Un procedimiento para preparar derivados de isoquinolina | |
| DE3885978D1 (de) | Cephemverbindungen und Verfahren zu ihrer Herstellung. | |
| ATE48840T1 (de) | Benzimidazole. | |
| FI871424A7 (fi) | Foerfarande foer framstaellning av foereningar med tvao ringar, och nya mellanprodukter. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 20060814 |